Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma

Cancer

Volumn 85, Issue 1, 1999, Pages 231-239

  Sakakibara, Masae ^a   Koizumi, Shoichi ^a   Saikawa, Yutaka ^a   Wada, Hideo ^a   Ichihara, Tsuyoshi ^a   Sato, Hiroshi ^b   Horita, Seiki ^c   Mugishima, Hideo ^d   Kaneko, Yasuhiko ^e   Koike, Kenichi ^f  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SAITAMA CANCER CENTER   (Japan)

^f SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gelatinase A; Membrane type matrix metalloproteinase 1; Metastasis; Neuroblastoma

Indexed keywords

COLLAGENASE; GELATIN; GELATINASE A; MONOCLONAL ANTIBODY; NEURON SPECIFIC ENOLASE;

ADOLESCENT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; ZYMOGRAPHY;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; ENZYME PRECURSORS; FEMALE; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEUROBLASTOMA; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0032953789     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<231::AID-CNCR31>3.0.CO;2-3     Document Type: Article

References (36)

1. Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Childrens Cancer Study Group A. Cancer 1971;27:374-8.
2. Evans AE, D'Angio GJ, Propert K, Anderson J, Hann HW. Prognostic factors in neuroblastoma. Cancer 1987;59: 1853-9.
3. Shimada H, Chatten J, Newton WA Jr., Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
4. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984;311:231-5.
5. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
6. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224:1121-4.
7. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 1989;63:126-32.
8. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993;328:847-54.
9. Combaret V, Gross N, Lasset C, Frappaz P, Peruisseau G. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 1996;14:25-34.
10. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
11. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
12. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992;7: 77-83.
13. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988;263:6579-87.
14. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264:17213-21.
15. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986;55:1037-57.
16. Brown PD, Bloxidge RE, Anderson E, Howell A. Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 1993;11:183-9.
17. Yamagata S, Yoshii Y, Suh JG, Tanaka R, Shimizu S. Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 1991;59:51-5.
18. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994;370:61-5.
19. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 1995;270:23013-20.
20. Monsky WL, Kelly T, Lin CY, Yeh Y, Stetler-Stevenson WG, Mueller SC, et al. Binding and localization of Mr 72,000 matrix metalloproteinase at cell surface invadopondia. Cancer Res 1993;53:3159-64.
21. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, et al. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 1993;53:1397-402.
22. Veas RG, Schweigerer L, Medina MA. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumor cells. Effects of tumor cell proliferation modulators on gelatinolytic activity. J Cancer Res Clin Oncol 1995;121:275-8.
23. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 1996;56: 2707-10.
24. Takino T, Sato H, Yamamoto E, Seiki M. Cloning of a gene potentially encoding a novel matrix metalloproteinase having a trans-membrane domain at the C-terminus. Gene 1995;115:293-8.
25. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995;64:355-9.
26. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995;92:2730-4.
27. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995;55:3263-6.
28. Sawaguchi S, Kaneko M, Uchino J, Takeda T, Iwafuchi M, Matsuyama S, et al. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the study group of Japan. Cancer 1990;66:1879-87.
29. Mugishima H, Iwata M, Okabe I, Sanuki E, Onuma N, Fujimoto T, et al. Autologous bone marrow transplantation in children with advanced neuroblastoma. Cancer 1994;74: 972-7.
30. Suita S, Zaizen Y, Yano H, Akiyama H, Sera Y, Takamatsu H, et al. How to deal with advanced cases of neuroblastoma detected by mass screening: A report from the pediatric oncology study group of the Kyushu area of Japan. J Pediatr Surg 1994;29:599-603.
31. Miller R, Siegmund D. Maximally selected chi square statistics. Biometrics 1982;38:1011-6.
32. Kaplan ES, Meier P. Non parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-81.
33. Mantel H, Haenzel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
34. Yamada T, Yoshiyama Y, Sato H, Seiki M, Shinagawa A, Takahashi M. White matter microglia produce membrane-type matrix metalloproteinase, an activator of gelatinase A, in human brain tissues. Acta Neuropathol 1995;90:421-4.
35. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996;56:384-92.
36. Bessho F, Hashizume K, Nakajo T, Kamoshita S. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 1991;19:237-41.